These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Molecular structure of the Mycobacterium tuberculosis virulence factor, mycolic acid, determines the elicited inflammatory pattern. Vander Beken S; Al Dulayymi JR; Naessens T; Koza G; Maza-Iglesias M; Rowles R; Theunissen C; De Medts J; Lanckacker E; Baird MS; Grooten J Eur J Immunol; 2011 Feb; 41(2):450-60. PubMed ID: 21268014 [TBL] [Abstract][Full Text] [Related]
3. Incorporation of immunostimulatory motifs in the transcribed region of a plasmid DNA vaccine enhances Th1 immune responses and therapeutic effect against Mycobacterium tuberculosis in mice. Wu J; Ma H; Qu Q; Zhou WJ; Luo YP; Thangaraj H; Lowrie DB; Fan XY Vaccine; 2011 Oct; 29(44):7624-30. PubMed ID: 21856352 [TBL] [Abstract][Full Text] [Related]
4. Trans-cyclopropanation of mycolic acids on trehalose dimycolate suppresses Mycobacterium tuberculosis -induced inflammation and virulence. Rao V; Gao F; Chen B; Jacobs WR; Glickman MS J Clin Invest; 2006 Jun; 116(6):1660-7. PubMed ID: 16741578 [TBL] [Abstract][Full Text] [Related]
5. Conformational folding of mycobacterial methoxy- and ketomycolic acids facilitated by α-methyl trans-cyclopropane groups rather than cis-cyclopropane units. Villeneuve M; Kawai M; Horiuchi K; Watanabe M; Aoyagi Y; Hitotsuyanagi Y; Takeya K; Gouda H; Hirono S; Minnikin DE Microbiology (Reading); 2013 Nov; 159(Pt 11):2405-2415. PubMed ID: 24014663 [TBL] [Abstract][Full Text] [Related]
6. CD1b-restricted GEM T cell responses are modulated by Chancellor A; Tocheva AS; Cave-Ayland C; Tezera L; White A; Al Dulayymi JR; Bridgeman JS; Tews I; Wilson S; Lissin NM; Tebruegge M; Marshall B; Sharpe S; Elliott T; Skylaris CK; Essex JW; Baird MS; Gadola S; Elkington P; Mansour S Proc Natl Acad Sci U S A; 2017 Dec; 114(51):E10956-E10964. PubMed ID: 29158404 [TBL] [Abstract][Full Text] [Related]
7. A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice. Geluk A; van den Eeden SJ; van Meijgaarden KE; Dijkman K; Franken KL; Ottenhoff TH Vaccine; 2012 Dec; 30(52):7513-21. PubMed ID: 23103299 [TBL] [Abstract][Full Text] [Related]
8. Modulation of immune responses in mice to recombinant antigens from PE and PPE families of proteins of Mycobacterium tuberculosis by the Ribi adjuvant. Chaitra MG; Nayak R; Shaila MS Vaccine; 2007 Oct; 25(41):7168-76. PubMed ID: 17709160 [TBL] [Abstract][Full Text] [Related]
9. Analysis of the structure of mycolic acids of Mycobacterium simiae reveals a particular composition of alpha-mycolates in strain 'habana' TMC 5135, considered as immunogenic in tuberculosis and leprosy. Mederos L; Valdivia JA; Valero-Guillén PL Microbiology (Reading); 2007 Dec; 153(Pt 12):4159-4165. PubMed ID: 18048929 [TBL] [Abstract][Full Text] [Related]
10. Protection against Mycobacterium tuberculosis infection offered by a new multistage subunit vaccine correlates with increased number of IFN-γ+ IL-2+ CD4+ and IFN-γ+ CD8+ T cells. Wang X; Zhang J; Liang J; Zhang Y; Teng X; Yuan X; Fan X PLoS One; 2015; 10(3):e0122560. PubMed ID: 25822536 [TBL] [Abstract][Full Text] [Related]
11. TLR2-targeted secreted proteins from Mycobacterium tuberculosis are protective as powdered pulmonary vaccines. Tyne AS; Chan JG; Shanahan ER; Atmosukarto I; Chan HK; Britton WJ; West NP Vaccine; 2013 Sep; 31(40):4322-9. PubMed ID: 23880366 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant formulation structure and composition are critical for the development of an effective vaccine against tuberculosis. Orr MT; Fox CB; Baldwin SL; Sivananthan SJ; Lucas E; Lin S; Phan T; Moon JJ; Vedvick TS; Reed SG; Coler RN J Control Release; 2013 Nov; 172(1):190-200. PubMed ID: 23933525 [TBL] [Abstract][Full Text] [Related]
13. Inflammatory Properties and Adjuvant Potential of Synthetic Glycolipids Homologous to Mycolate Esters of the Cell Wall of Mycobacterium tuberculosis. Tima HG; Al Dulayymi JR; Denis O; Lehebel P; Baols KS; Mohammed MO; L'Homme L; Sahb MM; Potemberg G; Legrand S; Lang R; Beyaert R; Piette J; Baird MS; Huygen K; Romano M J Innate Immun; 2017; 9(2):162-180. PubMed ID: 27855374 [TBL] [Abstract][Full Text] [Related]
14. Increased levels of interferon-gamma primed by culture filtrate proteins antigen and CpG-ODN immunization do not confer significant protection against Mycobacterium tuberculosis infection. Fonseca DM; Silva CL; Paula MO; Soares EG; Marchal G; Horn C; Bonato VL Immunology; 2007 Aug; 121(4):508-17. PubMed ID: 17433075 [TBL] [Abstract][Full Text] [Related]
15. Induction of Shang S; Kats D; Cao L; Morgun E; Velluto D; He Y; Xu Q; Wang CR; Scott EA Front Immunol; 2018; 9():2709. PubMed ID: 30538700 [TBL] [Abstract][Full Text] [Related]
16. Microstructured liposome subunit vaccines reduce lung inflammation and bacterial load after Mycobacterium tuberculosis infection. Trentini MM; de Oliveira FM; Gaeti MP; Batista AC; Lima EM; Kipnis A; Junqueira-Kipnis AP Vaccine; 2014 Jul; 32(34):4324-32. PubMed ID: 24951861 [TBL] [Abstract][Full Text] [Related]
17. Mucosal delivery switches the response to an adjuvanted tuberculosis vaccine from systemic TH1 to tissue-resident TH17 responses without impacting the protective efficacy. Orr MT; Beebe EA; Hudson TE; Argilla D; Huang PW; Reese VA; Fox CB; Reed SG; Coler RN Vaccine; 2015 Nov; 33(48):6570-8. PubMed ID: 26541135 [TBL] [Abstract][Full Text] [Related]
18. Liposomal delivery of lipoarabinomannan triggers Mycobacterium tuberculosis specific T-cells. Kallert S; Zenk SF; Walther P; Grieshober M; Weil T; Stenger S Tuberculosis (Edinb); 2015 Jul; 95(4):452-62. PubMed ID: 26043674 [TBL] [Abstract][Full Text] [Related]
20. Location of functional groups in mycobacterial meromycolate chains; the recognition of new structural principles in mycolic acids. Watanabe M; Aoyagi Y; Mitome H; Fujita T; Naoki H; Ridell M; Minnikin DE Microbiology (Reading); 2002 Jun; 148(Pt 6):1881-1902. PubMed ID: 12055308 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]